An EHR strategy can't be measured in clicks, says Lilly exec

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.

W2O Group acquires Sentient Interactive

W2O Group acquires Sentient Interactive

This is W2O Group's third acquisition since a private-equity firm took an investment in May.

How pharma can stay compliant when using programmatic

How pharma can stay compliant when using programmatic

The risk of fraud is also very real, especially in an industry that already faces privacy and compliance challenges, one expert says.

BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists

BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists

Boehringer Ingelheim and Eli Lilly have to position their third-in-class diabetes medication Jardiance as a heart drug.

Five things for pharma marketers to know: Thursday, December 8, 2016

Five things for pharma marketers to know: Thursday, December 8, 2016

A California lawmaker reintroduces drug-pricing bill; France, Poland, Spain, and Sweden lobby to host EMA; drug stocks fall after Trump's comments

Spectrum names Jonathan Wilson CEO

Spectrum names Jonathan Wilson CEO

Wilson will succeed founder and CEO John Seng.

Senate passes Cures Act, which opens door to use of real-world evidence

Senate passes Cures Act, which opens door to use of real-world evidence

The bill now heads to President Obama's desk. He is expected to sign the sweeping piece of legislation.

Five things for pharma marketers to know: Wednesday, December 7, 2016

Five things for pharma marketers to know: Wednesday, December 7, 2016

Trump puts pharma on notice over drug prices; Mylan lays off nearly 10% of its workforce; Pfizer slapped with U.K. antitrust fine

GSK and Propeller Health's smart inhaler aims to improve adherence in clinical trials

GSK and Propeller Health's smart inhaler aims to improve adherence in clinical trials

The drugmaker is using Propeller Health's sensor technology to find new ways to improve adherence in clinical studies.

Five things for pharma marketers to know: Tuesday, December 6, 2016

Five things for pharma marketers to know: Tuesday, December 6, 2016

Prices of Viagra and Cialis triple since 2010; AstraZeneca's Tagrisso slows lung-cancer progression compared to chemo; Novo Nordisk to limit price increases

Rock Health's Bill Evans on finding a career with meaning

Rock Health's Bill Evans on finding a career with meaning

The Roche veteran says that people who work in digital health need to touch others in a meaningful way.

Matt Brown leaves Guidemark Health after merger falls through

Matt Brown leaves Guidemark Health after merger falls through

The agency is owned by High Road Capital Partners. Sophy Regelous, the company's chief operating officer, will now lead the agency.

Five things for pharma marketers to know: Monday, December 5, 2016

Five things for pharma marketers to know: Monday, December 5, 2016

The FDA approves new indication for Jardiance; Novartis' CAR-T therapy eliminates leukemia in 82% of patients in trial; doctors report risks associated with immunotherapy

Prescription drug spending rises 9% in 2015, to $324 billion

Prescription drug spending rises 9% in 2015, to $324 billion

However, the rate of drug spending slowed compared to last year, according to an analysis by the CMS.

As users move to mobile, Google says they made 200 million queries for info about cancer drugs

As users move to mobile, Google says they made 200 million queries for info about cancer drugs

The search-engine giant says that one in 20 online searches are related to healthcare, and more users are using mobile to consume media.

Five things for pharma marketers to know: Friday, December 2, 2016

Five things for pharma marketers to know: Friday, December 2, 2016

Regeneron and Pfizer CEOs argue about the industry's reputation; Mylan CEO defends the EpiPen; Pfizer and IBM to partner on cancer immunotherapies

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.

Heather Bresch's appearance at industry summit came after she declined to attend a congressional hearing scheduled for the same day.

Five things for pharma marketers to know: Thursday, December 1, 2016

Five things for pharma marketers to know: Thursday, December 1, 2016

Valeant doesn't plan to offload Salix; heart docs back Califf as commish; Saunders says pricing issues aren't affected by election

House passes 21st Century Cures Act that would allow some off-label sharing

House passes 21st Century Cures Act that would allow some off-label sharing

The bill includes two provisions that would address drugmakers' calls for clarity on sharing off-label information with payers and regulators.

Agency Spotlight

Featured Listings

LevLane

LevLane

Featured Work: Kennedy Health brings sophisticated healthcare to South Jersey, and we wanted this ...

OPINION

Email Newsletters